Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Preventing Atrial Fibrillation After Heart Surgery with Amiodarone

Official title: Assessment of Intra-Operative Atrial Fibrillation Inducibility As a Screening Tool to Prevent Post-Operative Atrial Fibrillation With Prophylaxis Amiodarone

Run by Stanford University · NCT03868150 · Data updated 2026-11-12

This study is testing if giving amiodarone before heart surgery can help prevent atrial fibrillation in patients who are at risk for it.

More Atrial Fibrillation trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment600 (estimated)
SponsorStanford University
Academic / other
Locations1 site (Stanford, California)
StatusRecruiting
StartedMarch 1, 2017
Main results expectedDecember 31, 2030
Study endsDecember 31, 2050
Registry record updatedFebruary 17, 2026
Trial IDNCT03868150 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients scheduled for first-time non-emergent open-heart surgery with normal sinus rhythm and no history of atrial fibrillation.

Probably not a fit

Patients with a prior history of atrial fibrillation or those requiring surgical treatment for atrial arrhythmias will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the prevention of postoperative atrial fibrillation (POAF) in patients undergoing first-time cardiac surgery. Prior to cardiopulmonary bypass, patients will undergo rapid atrial pacing to assess their heart's susceptibility to atrial fibrillation. Those who show inducible atrial fibrillation will be randomly assigned to receive either prophylactic amiodarone treatment or no treatment, while those who do not show inducibility will receive standard postoperative care. The study aims to evaluate the effectiveness of this approach in reducing the incidence of POAF.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the occurrence of postoperative atrial fibrillation, improving recovery and outcomes for cardiac surgery patients.

How similar studies have gone: Other studies have explored similar preventive measures for postoperative atrial fibrillation, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients scheduled for first-time non-emergent open-heart surgery for coronary artery bypass graft (CABG) revascularization, valvular repair or replacement, combined CABG with valve repair or replacement, or valve sparing aortic root repair
* Normal sinus rhythm
* No documented history of atrial fibrillation

Exclusion Criteria:

* Prior surgical procedures involving heart surgery and cardiopulmonary bypass
* Any prior documented history of atrial fibrillation, atrial flutter or atrial tachycardia lasting longer than 30 seconds
* Prior history of Amiodarone treatment for the management of supraventricular tachy-arrhythmias
* Patients requiring surgical treatment of atrial arrhythmias such as pulmonary vein isolation or Maze procedure.

Where it's running

  • Stanford University
    Stanford, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.